BioNTech SE
@BioNTech_Group
Global interim Phase 2 data in extensive-stage small cell lung cancer presented at #WCLC25:
Investigational approach designed to target PD-L1 and VEGF-A in a single molecule.
Full PR: bit.ly/3I1dZVs
Investigational approach designed to target PD-L1 and VEGF-A in a single molecule.
Full PR: bit.ly/3I1dZVs
0 24